We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Review |

Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions A Meta-analysis

Michael K. Gould, MD, MS; Courtney C. Maclean, BA; Ware G. Kuschner, MD; Chara E. Rydzak, BA; Douglas K. Owens, MD, MS
JAMA. 2001;285(7):914-924. doi:10.1001/jama.285.7.914.
Text Size: A A A
Published online

Context Focal pulmonary lesions are commonly encountered in clinical practice, and positron emission tomography (PET) with the glucose analog 18-fluorodeoxyglucose (FDG) may be an accurate test for identifying malignant lesions.

Objective To estimate the diagnostic accuracy of FDG-PET for malignant focal pulmonary lesions.

Data Sources Studies published between January 1966 and September 2000 in the MEDLINE and CANCERLIT databases; reference lists of identified studies; abstracts from recent conference proceedings; and direct contact with investigators.

Study Selection Studies that examined FDG-PET or FDG with a modified gamma camera in coincidence mode for diagnosis of focal pulmonary lesions; enrolled at least 10 participants with pulmonary nodules or masses, including at least 5 participants with malignant lesions; and presented sufficient data to permit calculation of sensitivity and specificity were included in the anaylsis.

Data Extraction Two reviewers independently assessed study quality and abstracted data regarding prevalence of malignancy and sensitivity and specificity of the imaging test. Disagreements were resolved by discussion.

Data Synthesis We used a meta-analytic method to construct summary receiver operating characteristic curves. Forty studies met inclusion criteria. Study methodological quality was fair. Sample sizes were small and blinding was often incomplete. For 1474 focal pulmonary lesions of any size, the maximum joint sensitivity and specificity (the upper left point on the receiver operating characteristic curve at which sensitivity and specificity are equal) of FDG-PET was 91.2% (95% confidence interval, 89.1%-92.9%). In current practice, FDG-PET operates at a point on the summary receiver operating characteristic curve that corresponds approximately to a sensitivity and specificity of 96.8% and 77.8%, respectively. There was no difference in diagnostic accuracy for pulmonary nodules compared with lesions of any size (P = .43), for semiquantitative methods of image interpretation compared with qualitative methods (P = .52), or for FDG-PET compared with FDG imaging with a modified gamma camera in coincidence mode (P = .19).

Conclusions Positron emission tomography with 18-fluorodeoxyglucose is an accurate noninvasive imaging test for diagnosis of pulmonary nodules and larger mass lesions, although few data exist for nodules smaller than 1 cm in diameter. In current practice, FDG-PET has high sensitivity and intermediate specificity for malignancy.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?


Figure 1. Individual Study Estimates of Sensitivity and 1 − Specificity
Graphic Jump Location
Asterisks indicate studies that did not enroll any participants with benign nodules or masses and, therefore, reported sensitivity but not specificity. In these studies, results for sensitivity should be interpreted with caution because such studies may use a test threshold that maximizes sensitivity without sacrificing specificity. FDG-PET indicates positron emission tomography with 18-fluorodeoxyglucose; error bars, 95% confidence intervals. Three studies12,72,73 examined both FDG-PET and FDG with a modified gamma camera in coincidence mode; these 3 studies are listed twice.
Figure 2. Summary Log ORs for Studies of FDG-PET and FDG With a Modified Gamma Camera in Coincidence Mode
Graphic Jump Location
For lesions of any size, the summary log odds ratio (OR) for positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) corresponds to a maximum joint sensitivity and specificity of 91.2% (95% CI, 89.1%-92.9%). N indicates number of lesions; error bars, 95% confidence intervals (CIs).
Figure 3. Summary ROC Curves and 95% Confidence Intervals for Imaging Focal Pulmonary Lesions of Any Size and Imaging Pulmonary Nodules With FDG-PET
Graphic Jump Location
In both panels, black diamonds indicate individual study estimates of sensitivity and 1 − specificity. Gray squares indicate maximum joint sensitivity and specificity (a global measure of test accuracy) and gray triangles represent the points on the receiver operating characteristic (ROC) curve at which positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) approximately operates in current practice for detecting malignancy in lesions of any size (A) and in pulmonary nodules (B).



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

565 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles

Users' Guides to the Medical Literature
Clarifying Your Question

Users' Guides to the Medical Literature
Three Examples of Question Clarification